http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002045624-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate | 2001-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0778d5f1b1fa4307f45485f56bafad4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70b3c40a045639b94d6f21dd0da47e56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_047e2848f34307d0b3e1a1b8bc795173 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db9fea14c33e03763a6a5a8dc23966fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1bc399621ba931a556ac9d00e3ac1db |
| publicationDate | 2002-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2002045624-A1 |
| titleOfInvention | Aralkyl diaxabicycloalkane derivatives for CNS disorders |
| abstract | Certain aralkl diazabicycloalkyl compounds are described for treatment of CNS disorders such as cerebral ischemia, psychoses and convulsions. Compounds of particular interest are of the formula: n n n wherein each of R 1 , R 4 , R 5 , R 6 and R 7 is independently selected from hydrido, lower alkyl, benzyl, and haloloweralkyl; wherein each of R 2 , R 3 and R 8 through R 11 is independently selected from hydrido, hydroxy, loweralkyl, benzyl, phenols, benzyloxy and haloloweralkyl; wherein n is an integer of from four to six; wherein m is an integer of from two to four; wherein A is selected from phenyl, naphthyl, benzothienyl, benzofuranyl and thienyl; wherein any of the foregoing A groups can be further substituted with one or more substituents independently selected from hydrido, hydroxy, loweralkyl, loweralkoxy, halo, haloloweralkyl, amino, monoloweralkylamino and diloweralkylamino; or a pharmaceutically acceptable salt thereof. |
| priorityDate | 1992-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 352.